Lexaria Bioscience Corp. announced new appointments to its scientific advisory board, each of whom will contribute advice and recommendations and support related to the Company’s scientific research and product development. Dr. Dwayne Godwin is Dean of the Graduate School and Professor in the Departments of Neurobiology and Anatomy and the Institute for Regenerative Medicine at Wake Forest University. He is a neuroscientist with extensive experience in studies of synaptic pharmacology of the brain and translational interests in the physiological basis and neuroimaging of brain injury, alcohol abuse, epilepsy and seizure, Alzheimer’s and PTSD. Dr. Terry D. Blumenthal is Professor, Psychology and Neuroscience, at Wake Forest University, and is past president of the Society for Psychophysiological Research. Dr. Carla Lema Tome is an industry consultant an Adjunct Assistant Professor of Neurobiology and Anatomy at Wake Forest University School of Medicine. She is widely published on topics including but not limited to cellular and molecular neuroscience, inflammation, neurodegeneration, and cancer biology. She has extensive experience in global medical and commercial strategy consulting with emphasis on integrated clinical development, asset and portfolio strategy, launch planning payer research and payer value communications. Dr. Matthew Fraser, an Associate Professor and Director of Basic Science Research in the Department of Surgery, Division of Urology at Duke University Medical Center.